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Summary The accurate determination of exposure to environmental tobacco smoke is notoriously difficult.
There have been to date two approaches to determining this exposure in the study of association of passive
smoking and lung cancer: the biochemical approach, using cotinine in the main as a marker, and the
epidemiological approach. Typically results of the former have yielded much lower relative risk than the latter,
and have tended to be ignored in favour of the latter, although there has been considerable debate as to the
logical basis for this. We settle this question by showing that, using the epidemiologically based meta-analysis
technique of Wald et al. (1986), and misclassification models in the EPA Draft Review (1990), one arrives
using all current studies at a result which is virtually identical with the biochemically-based conclusions of
Darby and Pike (1988) or Repace and Lowry (1990). The conduct of this meta-analysis itself raises a number
of important methodological questions, including the validity of inclusion of studies, the use of estimates
adjusted for covariates, and the statistical significance of estimates based on meta-analysis of the epidemio-
logical data. The best estimate of relative risk from spousal smoking is shown to be approximately 1.05-1.10,
based on either of these approaches; but it is suggested that considerable extra work is needed to establish
whether this is significantly raised.
Exposure to 'passive smoking', or environmental tobacco
smoke (ETS) is far from easy to measure accurately (Lee,
1988), since it is not a direct consequence of actions of the
'exposed' subjects. This means that standard research
methods have been particularly difficult to use in considering
the level of association between ETS and occurrence of
diseases, even when strong levels of association have been
reported between active smoking and those diseases.
In the 1970's it was accepted that either the levels of
exposure or the types of exposure to ETS were such that no
significant association between ETS and lung cancer existed.
In the last decade, however, there have been well over 20
published epidemiological studies which have sought to
investigate the association between exposure to ETS and lung
cancer. This epidemiological approach (see Sections 3, 4)
categorises exposure to ETS in terms of the smoking of
spouses (except for Kabat, 1990 who uses home exposure)
when the subject evaluated is a never-smoker, and then
adjusts for now well-established differential sampling biases.
The outcome assessed in these papers is usually occurrence of
general lung cancer, although several concentrate on or are
dominated by one specific form of this disease (e.g. Tricho-
poulos et al. (1981, 1983), who exclude adenocarcinoma, or
Garfinkel (1985) whose results conversely are dominated by
adenocarcinoma); but in general all types are considered.
Individual studies usually report overall relative risks or
odds ratios and assess whether these are significantly raised
from unity: that is, whether there is a significantly increased
risk of lung cancer associated with ETS. In most individual
studies, relative risks have not been significantly raised, but
this could be due to the small size of the studies; and over
the past 5 years there have been various evaluations using
'meta-analysis' of the overall risk of lung cancer following
exposure to ETS. The two best known are the NRC Report
(1986) and the paper by Wald et al. (1986). There are marked
similarities in their evaluations, in that both calculate a 'com-
bined relative risk', estimate the extent of bias due to differ-
ential misclassification of smokers and background exposure
problems, and evaluate significance from the confidence
levels established from the meta-analysis adjusted for mis-
classification, as in Sections 3 and 4 below. The EPA Draft
Review (1990) and the recent review paper by Repace and
Lowry (1990) also follow this pattern. These meta-analyses
typically show a combined excess risk of around 0.3-0.5 for
exposure to such spousal smoking, but this has been criti-
cised largely because of the difficulties in accurate determina-
tion of exposure status (Lee, 1988; Uberla, 1987).
Simultaneously with the epidemiological studies, there has
been a second and more direct approach to the problem of
estimating levels of ETS exposure. The biochemical marker
approach (see Section 2) attempts to measure takeup of
nicotine derivatives, converts this to a 'cigarette equivalent'
figure, and estimates a relative risk based on extrapolating
the observed relative risk for active smoking.
Both the NRC Report (1986) and the EPA Draft Review
(1990) review this biochemical 'cigarette-equivalent' app-
roach, as does the review by Repace and Lowry (1990). All
find substantially lower results for the excess risk using this
biochemical marker method, of the order of 0.03-0.10, and
this is supported by a similar model-based approach of
Darby and Pike (1988).
This discrepancy clearly presents some methodological pro-
blems as to which level of association is correct, and by
implication which approach (if either) to determining expo-
sure is reliable. This has engendered considerable recent and
rather inconclusive debate (see Darby & Pike, 1988; Wald et
al., 1990; 1991a,b; Lee et al., 1991a,b).
Since the reviews cited above have been carried out, results
from a number of further epidemiological studies have been
published. These enable a revised calculation of the risk from
the epidemiological data, and one purpose of our paper is to
carry out such a revised assessment.
We show that after the now-standard 'Wald adjustment'
for differential misclassification, the two methods can be
reconciled to provide an estimate of the relative risk of lung
cancer associated with exposure to ETS, with a best current
estimate of around 1.07.
The conduct of the meta-analysis itself raises a number of
questions which are important in the use of this increasingly
popular tool for combining otherwise small and insignificant
studies, and these are discussed in relation to establishing this
estimate and its significance level.
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2. Cotinine, exposure to ETS and 'cigarette equivalents'
Cotinine is a metabolite of nicotine which is widely used as a
marker of exposure to tobacco smoke.
The NRC Report (1986, p. 226) states that 'urinary coti-
nine is at present the best marker of tobacco smoke intake
for passive smoking dosimetry'. Darby and Pike (1988) affirm
that cotinine has proved 'most useful in assessing average
daily exposure to tobacco smoke' and Repace and Lowry
(1990) agree that 'nicotine and cotinine are the best markers
(of exposure to ETS) currently available'.
The technique for assessing overall risk for exposure to
ETS from estimated active smoking risks using such a
marker uses an extrapolation argument. We assume that the
relative risk of lung cancer occurring for active smokers is
estimated to be RRA = 1 + EA, where EA is the known excess
risk for active smokers, and that we wish to estimate the
relative risk RRETS = (1 + EETS) of exposure to ETS, where
EETS denotes excess risk of this exposure.
Suppose the ratio of cotinine observed in the population
exposed to ETS when compared to cotinine observed in
active smokers is p. Since it has been estimated (cfDarby and
Pike (1988), NRC Report (1986)) that the half life ofcotinine
is about 50% longer in active smokers than in non-smokers,
if we assume that the continine ratio is directly linearly
linked to the ratio of excess risks, we get
p = 1.5 EETs/EA
There are then two parameters which must be estimated to
conclude this argument, namely p and EETS, and both have
been subjects of some debate.
The data of Wald and Ritchie (1984) has been used by, for
example, Wald et al. (1986) to provide an estimate of p of
around 1% for the ratio of cotinine observed in the popula-
tion exposed to ETS when compared to cotinine observed in
active smokers, whilst Jarvis et al. (1984) provide an estimate
of the ratio p of around 0.6% to 0.8%. Lee (1991a) argues
that the higher figure of 1% is biased upwards by possible
inclusion of smokers; Wald et al. (199la) argue that the
lower value of 0.6% to 0.8% is invalid due to problems of
definition and censoring of high values.
However, assuming that this range of 0.6-1% is at least
reasonable gives a value of EETS/EA of 0.4% to 0.66%.
The excess risk EA for active female smokers is variously
taken as seven (Wald et al., (1986) and the NRC Report
(1986)), or 11 (EPA Draft Review (1990)). Wald et al.
(1991a) argue that since the level of active smoking is by the
husband, the value of 11 for the excess risk of currently
active male smoking is relevant, although again Lee (199ib)
disputes this, and suggests that 7.3 is appropriate, being the
excess for ever-smoking males rather than currently active
smokers.
The lowest of these combinations of estimates yield a value
of RRETS= 1.028, whilst the highest estimates give RRETS =
1.08 for the relative risk of those exposed to environmental
tobacco smoke.
This range is also supported by other approaches using
cotinine which have been used to evaluate relative risk levels.
Darby and Pike (1988), in a detailed model of lung cancer
evolution, show that, if the dosage taken up by those expos-
ed to ETS is equivalent on average to active smoking of 0.1
cigarettes per day, then the relative risk for those exposed
from age 20 to age 65 extrapolated from active smoking
estimates will be 1.06 (see Table III of Darby and Pike
(1988)). Darby and Pike (1988) themselves state that relative
cotinine levels should indicate, from their detailed model, an
estimate for excess risk of around 'one seventeenth to one
fifth' of 0.5, i.e. a value of RRETS of around 1.03 to 1.10.
The value of 0.1 'cigarette equivalents' here is at the high
end of the range put forward by Darby and Pike (1988,
p. 830), although it is at the low end of the range suggested
by Vutuc (1984). Repace and Lowry (1990, p. 29) assert as
reasonable an assumption of uptake of nicotine by those
exposed to ETS of 0.5-1% of the uptake by active smokers.
This gives effectively the same level of 'cigarette equivalent'
as that used by Darby and Pike (1988).
Overall, the use of the cotinine argument is agreed by all
these authors to lead to a point estimate for the relative risk
to females of lung cancer associated with exposure to ETS of
around 1.03-1.10, with a 'best' value around RRETS of 1.06
being consistent with several different sources of available
published data.
Clearly there are questions open to dispute and perhaps in
need of further and rather better data. We note only that
although the suggested range of excess relative risks is wide
in relative terms (with a maximum over twice the minimum),
for all practical purposes 1.03-1.10 is a narrow set of values.
The real methodological problem is that this range of values
is much lower than that for the combined epidemiological
analyses of the NRC Report or the EPA Draft Review
(1990), which are around 1.3-1.5 after adjustment for well-
established differential biases. In the next section we follow
the Wald et al. (1986) meta-analysis and misclassification
adjustment approach to reevaluate these estimates with the
inclusion of new studies, and show that in fact they can be
reconciled with these dosimetric values.
3. The meta-analysis approach for epidemiological data
Combined estimate ofrelative risk
In any one study, data may be insufficient for accurate
estimates of relative risks to be made. This may be evidenced
by a statistically insignificant result, which may be due not to
lack of an association but to low power of the tests used and
low numbers in the study itself. The meta-analysis approach
allows for results to be 'pooled' over a number of com-
parable studies, in order to gain a more accurate estimate of
the real relationship to be made. There are different techni-
ques for such pooling, but the concept has been used widely
in recent assessment of the overall risk of passive smoking.
The use of this technique for epidemiological data was
pioneered in the paper by Wald et al. (1986), following its
development for clinical studies by Yusuf et al. (1985), and
the technique has been adopted in the NRC Report (1986)
and the EPA Draft Review (1990).
Since the NRC Report (1986) and the Wald et al. (1986)
paper have been published, a number of further studies of
the relationship between exposure to ETS and the risk of
lung cancer have been published. Many of these further
studies are included in the EPA Draft Review (1990),
although Varela (1987) is not included in the EPA Draft
Review meta-analysis, and Wu-Williams et al. (1990), Sobue
et al. (1990), Kabat (1990), Kalandidi et al. (1990), Liu et al.
(1991) and Fontham et al. (1991) have appeared since the
preparation of the EPA Draft Review (1990).
Table I gives the relative risks and associated confidence
intervals, calculated (except for Varela (1987)) using the logit
method, of all case-control studies on females published to
date. (The numbers ofmales who are never-smokers and who
contract lung cancer constitute a very small study popula-
tion. Addition of those investigations which report on males
does not materially change the results in Table I). The Varela
(1987) estimate is itself a combined estimate, using the
variance-weighted method of Wald et al. (1986), of the esti-
mates in Table II of Varela (1987).
Adjustingfor misclassification and bias
The paper of Wald et al. (1986) developed a technique for
estimating the effect of differential bias introduced by the
misclassification of smokers as non-smokers. The NRC
Report (1986), and the EPA Draft Review (1990) followed
this methodology, with the EPA Draft Review modifying it
somewhat to incorporate effects of misclassification of ex-
smokers directly.
The key observation of Wald et al. (1986) is that, because
smokers tend to marry smokers, if a study contains subjects
who are assessed as non-smokers when they are not, they are702 R.L. TWEEDIE & K.L. MENGERSEN
TableI Knownodds ratios forstudiesoffemalenon-smokers exposed
to ETS
Odds Upper Lower
Source ratio 95% CI 95% CI
Akiba et al. (1986) 1.52 2.63 0.87
Brownson et al. (1987) 1.52 5.96 0.39
Buffier et al. (1984) 0.80 1.90 0.34
Chan & Fung (1982) 0.75 1.30 0.43
Correa et al. (1983) 2.07 5.25 0.81
Fontham et al. (1991) 1.32 1.68 1.03
Gao et al. (1987) 1.19 1.73 0.82
Garfinkel et al. (1985) 1.23 1.87 0.81
Geng et al. (1988) 2.16 4.29 1.08
Humble et al. (1987) 2.34 6.75 0.81
Inoue & Hirayama (1988) 2.55 8.78 0.74
Kabat (1990) 0.90 1.76 0.46
Kabat & Wynder (1984) 0.79 2.45 0.25
Kalandidi et al. (1990) 1.57 2.83 0.87
Koo et al. (1987) 1.55 2.67 0.90
Lam T. et al. (1987) 1.65 2.35 1.16
Lam W. et al. (1985) 2.01 3.72 1.09
Lee et al. (1986) 1.03 2.55 0.41
Liu et al. (1991) 0.74 1.69 0.32
Pershagen et al. (1987) 1.27 2.15 0.75
Sobue et al. (1990) 1.31 1.96 0.87
Svensson et al. (1989) 1.26 2.81 0.57
Trichopoulos et al. (1983) 2.13 3.83 1.19
Varela (1987) 0.87 1.09 0.69
Wu et al. (1985) 1.41 3.67 0.54
Wu-Williams et al. (1990) 0.79 1.02 0.62
Combined analysis 1.17 1.28 1.06
more likely to be assessed as exposed to ETS: and thus the
estimate of relative risk of exposure to ETS will be exag-
gerated, due to the association of lung cancer with active
smoking for this group of 'deceivers'.
The EPA Draft Review (1990) estimated this 'spurious
excess risk' to be approximately 0.12, and adjusted their
combined risk downward by this amount. We have argued
elsewhere (Tweedie et al. (submitted)) that the true extent of
this misclassification bias is actually somewhat higher than
this, and Lee (1988) has an extensive discussion of the basis
for establishing an appropriate value. Lee (199la), using the
ratio of relative risks for ETS and active smokers, asserts
that a more extensive misclassification has also taken place,
although Wald et al. (199la,b) dispute this.
If we accept the (possibly conservative) EPA figure then we
would adjust downwards the observed value of 1.17 from the
combined analysis to a 'true' underlying value of RRETS=
1.05.
A second source of potential bias in the other direction is
the possibility that the so-called 'unexposed' group is in fact
exposed to a certain amount of 'background' ETS. Such
background exposure might result in a spuriously low value,
in contrast to the misclassification effect above. Wald et al.
(1986), the NRC Report (1986), and the EPA Draft Review
(1990) all use the following cotinine argument identical in
type to that in Section 2 to deduce the 'true' excess risk due
to ETS exposure, over the risk for a hypothetically complete-
ly unexposed group.
Suppose levels of cotinine are in principle known for non-
smokers exposed to ETS (defined as those with smoking
spouses) and for non-smokers supposedly unexposed.
If 6 is the level of cotinine in the supposedly unexposed
individuals, ifa is the level in supposed non-smokers exposed
to ETS, and if RRo is the observed relative risk for exposure
to ETS as found from epidemiological studies, then one may
find the true relative risk RRETS = 1 + a from solving
RRo = (1 + a)/(1 +6)
Wald et al. (1986) and the NRC Report (1986), based on
data of Wald and Ritchie (1984), adopted the ratio (ai/
6) = 3.0 in carrying out this analysis. The value of 3.0 is
supported to a certain extent in other literature (see 4-28 of
the EPA Draft Review (1990), which justifies and adopts the
value of 3.0, and also Table II of Jarvis et al. (1984), which
indicate values between 2.25 and 4 as reasonable for this
ratio).
If we assume there is such a 3-fold larger excess risk for
exposed non-smokers, then the real excess risks are given by
finding 36 from
RRo = (1 + 36)/(1 + 6)
If we use the value of 1.05 for RRo estimated above, then we
estimate a relative risk after adjustment on this basis of
RRETS= 1.076.
This is of course virtually identical with that found in
Section 2 from the dosimetric approach, and thus on the
basis of the most commonly acceptable data the two methods
appear to be essentially reconciled.
4. Methodological questions with meta-analysis
Inclusion ofstudies
The question ofwhich studies to include in a meta-analysis is
a difficult one. Theoretically meta-analysis is valid only inso-
far as one is combining comparable 'experiments', and in
particular comparable exposures, and there is good reason to
believe that whatever 'ETS' actually is, it is variable across
countries due not only to different chemical composition of
tobacco smokes but also widely differing social customs and
corresponding levels of exposure.
One could argue that studies from China should not be
included: tobacco smoking reportedly occurred on a wide
scale more recently there, and this may account for low
values such as in the recent studies of Liu et al. (1991) or
Wu-Williams et al. (1991). Clearly these recent results
account for part of the lowering in our current estimate from
those in 1986 or even 1990. But equally one would then have
to consider omitting Geng et al. (1988) or Lam (1987) or
Lam (1985) on such an argument; and these, conversely,
provide much of the increased overall relative risk.
A separate analysis of all US studies in Table I gives an
estimated relative risk of 1.10 with a 95% CI of (0.95, 1.27).
This might be a more conservative and safer estimate of the
level of association of ETS and lung cancer under western
conditions, although applying the Wald-EPA correction of
0.12 to this value actually reduces it below unity.
It has also been suggested that inclusion of the Varela
(1987) results, because they are only in thesis form and
relatively hard to access, is invalid. This seems an extremely
dangerous approach to meta-analysis. We have included the
results of Geng et al. (1988) despite the poor information of
the study available; the Varela (1987) study is (once located)
particularly well-documented in comparison to most pub-
lished studies, as it must be to be reviewed by thesis exam-
iners.
The real danger with any meta-analysis is the spurious
inflation of results due to omission of unpublished negative
results (see Chalmers & Buyse, 1988). One must include, at
least initially, all available studies unless there is clear and
documented reason to omit them, and the analysis above
does this.
Use ofadjusted estimates
There are many potential confounders of the relationship
between ETS and lung cancer: age, diet, occupation, have all
been suggested as possible variables for which results should
be adjusted. Use of such adjusted estimates in a meta-
analysis is usually not possible, since it confuses the relative
risks being combined unless the covariates used in adjustment
are the same across studies. In fact this is far from the case,
as is shown in Table II which gives odds ratios from raw
data, and published figures given as 'adjusted' in various
ways for covariates.
These adjustments, when given in the literature, have gonePASSIVE SMOKING AND LUNG CANCER 703
Table II Odds ratios and published 'adjusted' estimates of relative risk
Original Adjusted DifferenceFactors used
Humble et al. (1987)
Sobue et al. (1990)
Koo et al. (1987)
Wu et al. (1985)
Wu-Williams et al. (1990)
Lee et al. (1986)
Liu et al. (1991)
Varela (1987)
Brownson et al. (1987)
Kalandidi et al. (1990)
Garfinkel et al. (1985)
Gao et al. (1987)
Inoue & Hirayama (1988)
Lam et al. (1985)
Svensson et al. (1989)
Pershagen et al. (1987)
either way. In the recent work of Sobue et al. (1990), the
adjustment provides an estimate of0.94 compared with a raw
figure of 1.31; the estimates of Koo et al. (1987) and Wu-
Williams et al. (1990), on quite large studies, similarly drop
after adjustment for covariates; and conversely, the values of
Garfinkel et al. (1985), Gao et al. (1987) and Pershagen et al.
(1987) show increases in large studies.
The very obvious effects of confounding that the adjusted
estimates in Table II indicate must be a cause of concern.
Overall, therefore, we have chosen as have all other reviews
to work with the raw data.
We have also not included the three existing cohort studies
of Hirayama (1981; 1984), Gillis et al. (1984) or Garfinkel
(1981). The Gillis study is too small to influence the results.
With the other two major studies, there is a substantial
question as to whether to use raw data or age-adjusted data.
The age-adjusted results in Garfinkel (1981) are 1.18 with a
CI of (0.90, 1.54), a huge increase over the raw result of 0.53
with a 95% CI of (0.38, 0.73). There are a number ofways of
age-adjusting the Hirayama data (cf Ahlborn & Uberla,
1988; Tweedie (submitted)), and the latter version of this
gives a value of 1.15 as opposed to the value for non-
adjusted figures of 1.36 with a 95% CI of (0.95, 1.96).
These are wide variations, and as with the case-control
studies in Table II, age-adjustment does not give uniform
change. For the same reasons that we have avoided the
adjusted figures of Table II we have therefore omitted them
here, although this is not material as the age-adjusted values
do not alter the overall conclusion of our analysis.
Levels ofsignificance
The inclusion of new studies has changed the point estimate
from the combined analysis from 1.42 in the EPA Draft
Review (1990) to 1.17, although this is still, on the basis of
the variance from the combined analysis, an estimate which
is significant at over the 99% level.
As noted in the EPA Draft Review (1990), one can also
carry out a non-parametric test of the significance of the
data. Figure 1 shows these odds ratios in descending order,
with the 95% confidence intervals from Table I. The sign test
on these studies also indicates that, since only seven of 26
studies give values below 1.00, there is also a significant
rejection of the hypothesis of no association at the 99% level
on this non-parametric basis.
Moreover, as in previous studies we find a value from the
combined analysis which is still noticeably (if no longer
significantly) above that from the most recent evaluations of
biochemical marker data.
However, as observed by Wald et al. (1986), this signifi-
cance may be due to differential misclassification, and the
adjustments in the previous section take account of this. We
2.34 1.20 - 1.14 Age, ethnicity, sex
1.31 0.94 -0.37 Age
1.55 1.19 -0.36 Age, parity, education,
years since exposure ceased
1.41 1.20 -0.21 Age, active smoking
0.79 0.70 -0.09 Age, education, centre
1.03 1.00 -0.03 Age
0.74 0.77 0.03 Age, education, area
0.87 0.94 0.07 Age, sex, residence, etc
1.52 1.68 0.16 Age
1.57 1.92 0.35 Age, education, energy
intake, diet, interviewer
1.23 1.70 0.47 Age, hospital
1.19 1.70 0.51 Age, education
2.55 3.09 0.54 Age, year of death,
hospital
2.01 2.64 0.63 Not known
1.26 1.90 0.64 Age
1.27 2.40 1.13 Age
Figure 1 Relative risks of case control studies of females.
must then make a corresponding adjustment of the confi-
dence interval in this method. The standard approach has
been to adjust the confidence limits themselves by the same
amount, i.e. to propose a 95% CI of (0.92, 1.14) based on
Table I. This is almost certainly tighter than is warranted,
since many of the adjusting figures are themselves open to
error: see Mantel (1990). Indeed, one could well use the
results of recent studies, and the range of risks reported, as
support for the view that the previously reported results were
less accurate than the published CIs would indicate. How-
ever, even at these levels the meta-analysis shows the current
RRETS to be insignificantly raised at the 5% level. If the
correction of 0.12 is applied to the individual estimates, the
adjustment to Figure 1 shows this also implies that the
number of positive results is no longer significant at the 95%
level using the sign test, whilst changing the individual confi-
dence intervals in this way leaves only 7.5% of the results
significant at the 5% level, which is also very consistent with
a random effect.
There is clearly more work needed to develop statistical
methods for analysing this type of adjustment method, since
the interpretation of the statistical significance of the adjusted
data is now at a very subjective level.
5. Discussion
This paper addresses two questions of on-going importance,
not only in the assessment of the relationship between ETS
and occurrence of lung cancer, but also in the methodology
of evaluation of results which are inherently highly variable
and hard to assess.
The first is in the actual level of relative risk to be ascribed
to ETS. It has been argued (Wald et al., 1991b) that '. . .
passive smoking is a low dose exposure to a mixture of
substances that, at a high dose, is one of the best document-
ed and most potent causes of human cancer.' This biological704 R.L. TWEEDIE & K.L. MENGERSEN
plausibility is of course the rationale for seeking to assess, by
a number of means, whether the exposure incurred by non-
smokers does lead to a substantially increased relative risk,
and if so what the level is. It has therefore caused some
considerable confusion when two apparently valid approaches
to the problem give results which have seemingly differed by
an order of magnitude, and where to date the last word has
been the somewhat pessimistic statement by Wald et al.
(199ib) that it is '. . . not reasonable to expect a close
quantitative consistency . . .' between the two, and that given
the uncertainties in both methods '. . . it is remarkable that
the cotinine levels and the risk estimate [from epidemiological
studies] are as concordant as they are'.
There are of course very many difficulties and assumptions
in the meta-analysis method, especially in the combining of
epidemiological data. It can be criticised because of the
differences in the studies that are being put together: there is
no clear reason to believe that exposure to ETS in the United
Sates is the same exposure as in Asia, for example, nor that
the exposure for males is the same as for females. There is
also the possibility that negative studies may be omitted
(Chalmers, 1988), leading to an overestimate based on selec-
tive inclusion of positive studies and omission of negative
studies. There are well-accepted biases due to misclassifi-
cation in individual studies, and although the Wald technique
in Section 3 is now used routinely to adjust for these, it can
still be argued (cf Lee, 1991a,b) that the study results are
even more biased and the corresponding meta-analysis esti-
mate is too high.
But there are also difficulties and assumptions in the bio-
logical marker method. The argument assumes that excess
risk is linearly related to cotinine levels: this both assumes
that cotinine is an accurate quantitative measure of car-
cinogen intake if any, and moreover that it is linearly related
to the results of such carcinogen intake. It also relies on the
current levels of cotinine (which indicate nicotine intake over
the past 2-5 days) as being accurate estimates of the back-
ground and foreground exposure in the never-smokers over
their whole past history. Given that lung cancers are not a
product of short term exposures, this entails a major assump-
tion about the relative risks, and stability of those risks, over
long time periods.
Repace and Lowry (1990, Section 3) provide a good dis-
cussion of the benefits and dangers inherent in using cotinine
to evaluate risk, but conclude that several authorities have
found it an 'adequate basis for exposure assessment pur-
poses'.
It is somewhat surprising, then, that studies such as the
NRC Report (1986) or Repace and Lowry (1990) adopt the
epidemiologically based value for the overall relative risk to
females for exposure to ETS, rather than the values derived
from cotinine arguments.
The arguments for its rejection seem to be rather flimsy.
Darby and Pike (1989), p. 338) feel that 'it may simply be
that cotinine is not an adequate measure of the exposure of
non-smokers to the carcinogenic components of cigarette
smoke'. Repace and Lowry (1990, p. 31) state that the
'exposure-response relationship was found to be inconsistent
with the epidemiology of passive smoking, and was aban-
doned' in favour of other phenomenological approaches.
Despite this rejection of the cotinine argument for assess-
ing the overall relative risk ofexposure to ETS, it nonetheless
continues to be used to make major adjustments for 'back-
ground exposure' bias in the review papers cited above, with
an increase of virtually 50% in excess risk estimates based on
the biochemical argument marker as in Section 3. The logic
for this acceptance of cotinine in one part of the analysis and
its rejection in another is hard to support.
In this paper we have shown that, using the current
published studies of lung cancer and its association with
exposure to ETS, there is no need to reject either approach
because of the difference in results found.
We have shown that the range of estimates of 1.03-1.10
for the relative risk for exposure to ETS, as calculated by the
biological marker method in Section 2, is almost identical
with the best estimates from combined analysis of current
epidemiological studies given in Section 3, provided one
accepts the level of bias indicated for the case-control models
in the EPA Draft Review (1990), and makes a consistent use
of the cotinine argument to support a 50% increase in the
estimate by taking into account bias from background
exposure.
This result is at variance with those in the reviews to date,
and is some five to 10-fold weaker than the estimate in the
EPA Draft Review (1990). The methodology here is identical:
the only difference is in the addition of a number of new
studies.
What could cause such a change in estimates? Formally, it
is because the more recent studies include some large (and
hence presumed by the methodology to be more reliable)
recent studies with estimates of relative risk below the
previous combined estimate. Indeed, a considerable amount
of the change is due to the inclusion of the Kabat (1990),
Varela (1987), and Wu-Williams (1990) studies, although in
the other direction the Sobue et al. (1990) and Fontham
(1991) studies provide a higher estimate.
Such oscillating outcomes can be confusing, and meta-
analysis properly used should enable a clearer overview of
the true picture. The second contribution of this paper is to
indicate the caution that must be used in setting up such
analyses, and to caution against over-interpreting the point
estimates from the meta-analysis method. Our point estimate
(prior to adjustment for the two types of misclassification) is
1.17 and this seems much lower than the 1.42 of the EPA
Draft Report (1990). But the 95% confidence intervals for
these estimates are (1.06, 1.28) and (1.24, 1.63) respectively,
and although this indicates that the results of new studies are
overall below what might have been expected, they are cer-
tainly not giving a total different picture.
More substantially, however, the analysis we give shows
clearly the need to include all studies to gain an accurate
picture of the overall risk ratio.
There are still some serious methodological questions
about meta-analysis in the presence of such a difficult to
measure exposure as ETS, especially in the presence of differ-
ential misclassification. Mantel (1990) has argued that the
very low levels of excess risk reported in studies of ETS and
lung cancer are in the region where epidemiological studies
can never establish excess risk estimates significantly above
zero. Certainly, the contribution of random error at the
current state of analysis is not at all clear.
For this reason it is important to develop other techniques
which might help establish a figure with greater accuracy.
More and better controlled studies help to do this, but so do
indirect inferential methods such as the cotinine marker app-
roach. It is therefore of considerable value that the different
approaches appear to be reconcilable, rather than leaving
open a subjective judgement of which to accept.
The comments of Professors John Eccleston and Ian Saunders, and
the input from referees, have sharpened considerably our treatment
on the potential pitfalls with the meta-analysis method.
This work was initiated whilst both authors were at the School of
Information and Computing Sciences, Bond University, Australia.
References
AHBORN, W. & UBERLA, K. (1988). Passive smoking and lung
cancer: reanalyses of Hirayama's data. Indoor and Ambient Air
Quality, R. Perry, (ed.) London.
AKIBA, S., KATO, H. & BLOT, W.J. (1986). Exposure to ETS and lung
cancer among Japanese women. Cancer Res., 46, 4804- 4807.PASSIVE SMOKING AND LUNG CANCER 705
BROWNSON, R.C., REIF, J.S., KEEFE, T.J., FERGUSON, S.W. &
PRITZL, J.A. (1987). Risk factors for adenocarcinoma of the lung.
Am. J. Epidemiol., 125, 25-34.
BUFFLER, P.A., PICKLE, L.W., MASON, T.J. & CONSTANT, C. (1984).
The causes of lung cancer in Texas. In: Lung Cancer: Causes and
Prevention. Mizell, M. & Correa, P. (eds). Verlag Chemie Interna-
tional: New York, pp. 83-89.
CHALMERS, T.C. & BUYSE, M.E. (1988). Meta-analysis. In Data
Analysis for Clinical Medicine, Chalmers, T.C., (ed.). pp. 75-85.
International Uni Press, Rome.
CHAN, W.C. & FUNG, S.C. (1982). Lung cancer in non-smokers in
Hong Kong. Cancer Campaign, Vol. 6, Cancer Epidemiology,
pp. 199-202.
CORREA, P., PICKLE, L.W., FONTHAM, E.L., LIN, Y. & HAENSZEL,
W. (1983). Exposure to ETS and Lung Cancer. Lancet, ii, 595-
597.
DARBY, S.C. & PIKE, M.C. (1988). Lung cancer and passive smoking:
predicted effects from a mathematical model for cigarette smok-
ing and lung cancer. Br. J. Cancer, 58, 825-831.
EPA DRAFT REVIEW (1990). Health effects of passive smoking:
assessment of lung cancer in adults and respiratory disorders in
children. United States EPA, Washington.
FONTHAM, E.T.H., CORREA, P., WU-WILLIAMS, A., REYNOLDS, P.,
GREENBERG, A.S., BUFFLER, P.A., CHEN, V.W., BOYD, P.,
ALTERMAN, T., AUSTIN, D.F., LIFF, J. & GREENBERG, S.D.
(1991). Cancer in non-smoking women: a multicenter case-control
study. Cancer Epidemiol. Biomarkers & Prevention, 1, 35-43.
GAO, Y.-T., BLOT, W.J., ZHENG, W., ERSHOW, A.G., HSU, C.W.,
LEVIN, L.I., ZHANG, R. & FRAUMENI, J.F. (1987). Lung cancer
among Chinese women. Int. J. Cancer, 40, 604-609.
GARFINKEL, L. (1981). Time trends in lung cancer mortality among
non-smokers and a note on exposure to ETS. JNCI, 66, 1061-
1066.
GARFINKEL, L., AUERBACH, 0. & JOUBERT, L. (1985). Involuntary
smoking and lung cancer: a case study, JNCI, 75, 463-469.
GENG, G.-Y., LIANG, Z.H., ZHANG, A.Y. & WU, G.L. (1988). On the
relationship between smoking and female lung cancer. In Aoki,
M., Hisamichi, S. & Tominaga, S. (eds), Smoking and Health
1987, Proceedings of the 6th World Conference on Smoking and
Health, Tokyo.
GILLIS, C.R., HOLE, D.J., HAWTHORNE, V.M. & BOYLE, P. (1984).
The effect of environmental tobacco smoke in two urban com-
munities in the West of Scotland. Eur. J. Resp. Dis. (Suppl), 133,
121- 126.
HIRAYAMA, T. (1981). Non-smoking wives of heavy smokers have a
higher risk of lung cancer: a study from Japan. Br. Med. J., 282,
183-185.
HIRAYAMA, T. (1984). Lung cancer in Japan: effects of nutrition and
exposure to ETS. In Lung Cancer: Causes and Preventions. Verlag
Chemie Weinheim, pp. 175-195.
HUMBLE, C.G., SAMET, J.M. & PATHAK, D.R. (1987). Marriage to a
smoker and lung cancer risk. Am. J. Public Health, 77, 598-602.
INOUE, R. & HIRAYAMA, T. (1988). Passive smoking and lung
cancer in women. In Aoki, M., Hisamichi, A. & Tominaga, S.
(eds), Smoking and Health 1987, Proceedings of the 6th World
Conference on Smoking and Health, Tokyo.
JARVIS, M., TUNSTALL-PEDOE, H., FEYERABEND, C., VESEY, C. &
SALLOOJEE, Y. (1984). Biochemical markers of smoke absorption
and self-reported exposure to ETS. J. Epid. Comm. Health, 38,
335-339.
KABAT, G.C. (1990). Epidemiologic studies of the relationship
between passive smoking and lung cancer. Proc 1990 Toxicology
Forum, 187-199.
KABAT, G.C. & WYNDER, E.L. (1984). Lung cancer in nonsmokers.
Cancer, 53, 1214-1221.
KALANDIDI, A., KATSOUYANNI, K., VOROPOULOU, N., BASTAS,
G., SARACCI, R. & TRICHOPOULOS, D. (1990). Passive smoking
and diet in the aetiology of lung cancer among non-smokers.
Cancer Causes and Control, 1, 15-21.
KOO, L.C., HO, J.H., SAW, D. & HO, C. (1987). Measurement of
passive smoking and estimates of lung cancer risk among non-
smoking Chinese females. Int. J. Cancer, 39, 162-169.
LAM, T.H., KUNG, I.T.M., WONG, C.M., LAM, W.K., KLEEVENS,
J.W.L., SAW, D., HSU, C., SENIVERATNE, S., LAM, S.Y., LO, K.K.
& CHAN, W.C. (1987). Smoking, passive smoking and histological
types in lung cancer in Hong Kong Chinese women. Br. J.
Cancer, 6, 673-678.
LAM, W.K. (1985). A Clinical and Epidemiological Study of Car-
cinoma ofLung in Hong Kong, M.D. Thesis submitted to Univer-
sity of Hong Kong..
LEE, P.N., CHAMBERLAIN, J. & ALDERSON, M.R. (1986). Relation-
ship of passive smoking to risk of lung cancer and other
smoking-associated diseases. Br. J. Cancer, 54, 97-105.
LEE, P.N. (1988). Misclassification of Smoking Habits and Passive
Smoking: a Review of the Evidence. Springer-Verlag Berlin.
LEE, P.N. (1991a). Lung cancer and passive smoking: letter to the
editor. Br. J. Cancer, 63, 161-162.
LEE, P.N. (1991b). Lung cancer and passive smoking (continued):
letter to the editor. Br. J. Cancer, 64, 200.
LIU, Z., HE, X. & CHAPMAN, R.S. (1991). Smoking and other risk
factors for lung cancer in Xuanwei, China. Int. J. Epidemiol., 20,
26-31.
MANTEL, N. (1990). What is the epidemiological evidence for a
passive smoking - lung cancer association? In Indoor Air Quality,
H. Kasuga, (ed.) Springer-Verlag, Berlin, pp. 341-347.
NRC COMMITTEE ON PASSIVE SMOKING (1986). Environmental
Tobacco Smoke - Measuring Exposures and Assessing Health
Effects. National Academy Press, Washington.
PERSHAGEN, G., HRUBEC, Z. & SVENSSON, C. (1987). Passive smok-
ing and lung cancer in Swedish women. Am. J. Epidem., 125,
17-24.
REPACE, J.L. & LOWREY, A.H. (1990). Risk assessment methodo-
logies for passive smoking-induced lung cancer. Risk Anal., 10,
27-37.
SOBUE, T., SUZUKI, R., NAKAYAMA, N. & 14 others (1990). Passive
smoking among non-smoking women and the relationship
between indoor air pollution and lung cancer incidence - results
of a multicentre case controlled study. Gan to Rinsho, 36, 329-
332.
SVENSSON, C., PERSHAGEN, G. & KLOMINEK, J. (1989). Smoking
and passive smoking in relation to lung cancer in women. Acta
Oncol., 28, 623-629.
TRICHOPOULOS, D., KALANDIDI, A., SPARROS, L. & MACMAHON,
B. (1981). Lung cancer and exposure to ETS. Int. J. Cancer, 27,
1-4.
TRICHOPOULOS, D., KALANDIDI, A. & SPARROS, L. (1983). Lung
cancer and exposure to ETS. Conclusion of Greek study. Lancet,
ii, 677-678.
TWEEDIE, R.L., MENGERSEN, K.L. & ECCLESTON, J.A. (1992). Con-
founding and misclassification effects in case-control studies of
lung cancer incidence (submitted).
TWEEDIE, R.L. (1992). Age-adjustment in passive smoking studies
(submitted).
UBERLA, K. (1987). Cancer from passive smoking: hypothesis or
convincing evidence? Int. Arch. Occup. Environ. Health, 59,
421-437.
VARELA, L.R. (1987). Assessment of the Association Between Passive
Smoking and Lung Cancer, PhD Thesis, Yale University.
VUTUC, C. (1984). Quantitative aspects of passive smoking and lung
cancer. Prev. Med., 13, 698-704.
WALD, N.J. & RITCHIE, C. (1984). Validation of studies on lung
cancer in non-smokers married to smokers. Lancet, i, 1067.
WALD, N.J., NANCHAHAL, K., THOMPSON, S.G. & CUCKLE, H.S.
(1986). Does breathing other people's tobacco smoke cause lung
cancer? Br. Med. J., 293, 1217-1222.
WALD, N.J., NANCHAHAL, K., CUCKLE, H.S. & THOMPSON, S.G.
(1990). Lung cancer and passive smoking: letter to the editor. Br.
J. Cancer, 61, 337.
WALD, N.J., CUCKLE, H.S., NANCHAHAL, K. & THOMPSON, S.G.
(1991a). Response to the Letter from Dr P. Lee: Letter to the
editor. Br. J. Cancer, 63, 163.
WALD, N.J., CUCKLE, H.S., NANCHAHAL, K. & THOMPSON, S.G.
(1991b). Response to letter from Dr Lee: Letter to the editor. Br.
J. Cancer, 64, 201.
WU, A.H., HENDERSON, B.E., PIKE, M.C. & YU, M.C. (1985). Smok-
ing and other risk factors for lung cancer in women. JNCI, 74,
747-751.
WU-WILLIAMS, A.H. & SAMET, J.M. (1990). Environmental tobacco
smoke: exposure-response relationships in epidemiologic studies.
Risk Anal., 10, 39-48.
WU-WILLIAMS, A.H., DAI, X.D., BLOT, W., XU, Z.Y., SUN, X.W.,
XIAO, H.P., STONE, B.J., YU, S.F., FENG, Y.P., ERSHOW, A.G.,
SUN, J., FRAUMENTI, J.F. Jr & HENDERSON, B.E. (1990). Lung
cancer among women in north-east China. Br. J. Cancer, 62,
982-987.
YUSUF, S., PETO, R., LEWIS, J., COLLINS, R. & SLEIGHT, P. (1985).
Beta-blockade during and after myocardial infarction: an over-
view of the randomized trials. Prog. Cardiovasc. Dis., 27,
335-371.